A VC Perspective On Korean Bioventures: New Catalysts Needed To Jumpstart Activity

After ADC, GLP-1 Boom, What’s Next?

 
• By Jung Won Shin
  
venture capital
A VC's view on how it places its bets in the Korean bioventure sector (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Interviews

More from Leadership